Skip to content

Fetal RHD screening in clinical routine - experiences and considerations

This paper by Dr. Agneta Wikman, Associate Professor at Karolinska University Hospital explores an approach that uses non-invasive prenatal testing to determine the fetal RHD status, allowing targeted administration of antenatal anti-D prophylaxis only to those who will benefit from it. Learn more about the current strategies of fetal RHD and the experiences and considerations surrounding planning a fetal RHD screening program.

  • Current strategies of fetal RHD screening.
  • Requirements in clinical routine testing.
  • Planning a fetal RHD screening program.

Get access to the paper by filling out the form below